Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples
Thomas Liechti, Yaser Iftikhar, Massimo Mangino, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
Igor Kudryavtsev, Artem Rubinstein, А. С. Головкин, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1082-1082
Open Access | Times Cited: 31
Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
I. V. Kudryavtsev, N. A. Аrsentieva, Zoia R. Korobova, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1906-1906
Open Access | Times Cited: 31
Transient anti-interferon autoantibodies in the airways are associated with efficient recovery from COVID-19
Benjamin Babcock, Astrid Kosters, Devon J. Eddins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Chemokine receptors in COVID-19 infection
Claudia Gutierrez-Chavez, Shalom Aperrigue-Lira, Brando Ortiz-Saavedra, et al.
International review of cell and molecular biology (2024), pp. 53-94
Closed Access | Times Cited: 4
Restricting datasets to classifiable samples augments discovery of immune disease biomarkers
Gunther Glehr, Paloma Riquelme, Katharina Kronenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Delineating immune variation between adult and children COVID-19 cases and associations with disease severity
Alper Çevirgel, Martijn Vos, Anne Floor Holtrop, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs
Kevin S. O’Leary, Deyou Zheng
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Circulating inflammatory markers predict depressive symptomatology in COVID-19 survivors
Mariagrazia Palladini, Mario Gennaro Mazza, Rebecca De Lorenzo, et al.
Cytokine (2024) Vol. 186, pp. 156839-156839
Closed Access | Times Cited: 2
The role of inflammatory gene polymorphisms in severe COVID-19: a review
J Yip, Adrian Oo, Yan Ling Ng, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
A robust pipeline for high-content, high-throughput immunophenotyping reveals age- and genetics-dependent changes in blood leukocytes
Thomas Liechti, Sofie Van Gassen, Margaret H. Beddall, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 10, pp. 100619-100619
Open Access | Times Cited: 6
Interpretable clinical phenotypes among patients hospitalized with COVID-19 using cluster analysis
Eric Yamga, Louis Mullie, Madéleine Durand, et al.
Frontiers in Digital Health (2023) Vol. 5
Open Access | Times Cited: 5
COVID‐19 illness: Different comorbidities may require different immunological therapeutic targets
Elisa Gremese, Barbara Tolusso, Dario Bruno, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 12
Open Access | Times Cited: 4
Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation- and Immune-Related Pathways in T Lymphocytes from Patients with SARS-CoV-2 Infection with Pneumonia: Sex-Related Differences
Donatas Stakišaitis, Linas Kapočius, Vacis Tatarūnas, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 409-409
Open Access | Times Cited: 1
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19
Benjamin Babcock, Astrid Kosters, Devon J. Eddins, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Closed Access | Times Cited: 1
Prognostic Factors Associated with the Severe Course of a New Coronavirus Infection
Yu. B. Khamanova, Т. A. Frayfeld, K. R. Mullagalieva, et al.
Ural Medical Journal (2024) Vol. 23, Iss. 1, pp. 129-140
Open Access
Emerging severe acute respiratory syndrome coronavirus 2 variants and their impact on immune evasion and vaccine-induced immunity
Ramendra Pati Pandey, Sachin Kumar, Nageswara S. V. Rao, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2024)
Closed Access
Impaired mucosal IgA response in patients with severe COVID-19
Melyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access
T Regulatory Cell Subsets Do Not Restore for One Year After Acute COVID-19
Arthur Aquino, Ekaterina Zaikova, Olga Kalinina, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11759-11759
Open Access
Neutrophils restricted contribution of CCRL2 genetic variants to COVID-19 severity
Mattia Laffranchi, Elvezia Maria Paraboschi, Francisco M. Bianchetto-Aguilera, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41267-e41267
Open Access
Restricting datasets to classifiable samples augments discovery of immune disease markers
Gunther Glehr, Paloma Riquelme, Katharina Kronenberg, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Emerging SARS-CoV-2 Variants and Their Impact on Immune Evasion and Vaccine-Induced Immunity
Dablu Lal Gupta, D. N. Rao
(2023)
Open Access | Times Cited: 1
IgG from patients with mild or severe COVID‑19 reduces the frequency and modulates the function of peripheral mucosal-associated invariant T cells in PBMCs from healthy individuals
Nicolle Rakanidis Machado, Beatriz Fagundes, Iara Fernandes, et al.
Biomedical Reports (2023) Vol. 19, Iss. 6
Open Access | Times Cited: 1
B-Cell Responses to Sars-Cov-2 mRNA Vaccines
Lela Kardava, Clarisa M. Buckner, Susan Moir
Pathogens and Immunity (2022) Vol. 7, Iss. 2, pp. 93-119
Open Access | Times Cited: 1
Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs
Kevin S. O’Leary, Deyou Zheng
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top